Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)

Conditions:   Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital Warts;   Human Papillomavirus InfectionInterventions:   Biological: Comparator: GARDASIL;   Biological: Experimental: V503Sponsor:   Merck Sharp & Dohme Corp.Active, not recruiting - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials